ArticleCancer science2023

Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer.

Masatoshi Yamazoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.